Bacterial Quorum Sensing: A Double-Edged Sword in Cancer Development
Paniz MI, Tina RL, Farzaneh D, Bahreini F, Rezaei N.
Advanced Biology (Weinh). 2025 Jul 21:e00023.
Oral FcRn-targeted insulin: Challenges and current strategies
Aghakhani A, Bahreini F, Uversky VN, Rezaei N.
Journal of Drug Delivery Science and Technology, 2025.
Meeting Report on “The International Congress on Autoimmune Pre-disease (2024)”
Ohmes J, Mehrpourvan A, Bahreini F, et al.
JID Innovations 5(3), 100342, 2025.
Nanoparticles containing intracellular proteins modulate neutrophil functional and phenotypic heterogeneity
Raudszus L, Bahreini F, Allan S, Kalies K, Caldwell C.
Frontiers in Immunology 15, 1494400, 2025.
Inducing Apoptosis in Acute Myeloid Leukemia; Mechanisms and Limitations
Koolivand Z, Bahreini F, Rayzan E, Rezaei N.
Heliyon 11(1), 2024.
Current Therapeutic Approaches and Promising Perspectives of Using Bioengineered Peptides in Fighting Chemoresistance in Triple-Negative Breast Cancer
Azari M, Bahreini F, Uversky VN, Rezaei N.
Biochemical Pharmacology 210, 115459, 2023.
Clinical whole-exome sequencing analysis reveals a novel missense COL11A1 mutation
Mirtavoos-Mahyari H, Ajami S, Mehrtash A, Marashiyan SM, Bahreini F, et al.
Clinical Case Reports 10(11): e6574, 2022.
Biosynthesis of Copper Nanoparticles Using Aqueous Thymus daenensis (Celak) Flora and Investigation of Its Antifungal Activity
Ebrahimi K, Shir Ovand S, Mohammedi AA, Nabi-Afjadi M, Zalpoor H, Bahreini F.
Journal of Medical Microbiology and Infectious Diseases 10(3): 98–103, 2022.
Analysis of T Cell Repertoires of CD45RO CD4 T Cells in Cohorts of Patients with Bullous Pemphigoid: A Pilot Study
Niebuhr M*, Bahreini F*, Fähnrich A, Bomholt C, Bieber K, Schmidt E, Ibrahim S, Hammers CM, Kalies K.
Frontiers in Immunology 13, 1006941, 2022. (*equal contribution)
Modulation of Tumor Vasculature Network: Key Strategies
Taleb M, Mohammadkhani N, Bahreini F, Ovais M, Nie G.
Small Structures 3(6), 2100164, 2022.
Gallium Components-Based Drug Delivery: A Potential Treatment for COVID-19
Torabi S, Bahreini F, Rezaei N.
Infectious Disorders-Drug Targets 22(3): 1–3, 2022.
Protocol to Induce Follicular T Helper Cells, Germinal Centers, and Skin Lesions in Mouse Models for Skin Blistering Diseases
Bahreini F, Niebuhr M, Belde J, Bieber K, Westermann J, Kalies K.
Bio-protocol 12(10): e4414, 2022.
Protocol to Isolate Germinal Centers by Laser Microdissection
Bahreini F, Niebuhr M, Belde J, Westermann J, Kalies K.
Bio-protocol 12(11): e4431, 2022.
MicroRNAs and Diabetes Mellitus Type 1
Bahreini F, Rayzan E, Rezaei N.
Current Diabetes Reviews 18(2): 1–8, 2022.
The Role of Noncoding RNAs in Pituitary Adenoma
Bahreini F, Jabbari P, Gossing W, Aziziyan F, Frohme M, Rezaei N.
Epigenomics 13(17): 1421–1437, 2021.
microRNA-Related Single-Nucleotide Polymorphisms and Breast Cancer
Bahreini F, Rayzan E, Rezaei N.
Journal of Cellular Physiology 236(3): 1593–1605, 2021.
The Role of Angiotensin-Converting Enzyme 2 in COVID-19 Induced Lung Injury
Torabi S, Bahreini F, Rezaei N.
Acta Bio Medica: Atenei Parmensis 91(4): e2020142, 2020.
miR-559 Polymorphism rs58450758 is Linked to Breast Cancer
Bahreini F, Ramezani S, Shahangian SS, Salehi Z, Mashayekhi F.
British Journal of Biomedical Science 77(1): 29–34, 2020.